Financials

  • Market Capitalization 227.76 M
  • Employee 228
  • Founded 2008
  • CEO N/A
  • Website www.karyopharm.com
  • Headquarter Delaware, United States
  • FIGI BBG001J272L7
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-0.41
Price to sales ratio
0

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
3528
IVVD
Invivyd, Inc. - Common Stock
0.79 USD+1.28%-7.06%-2.47%+9.72%232.74 M USD
3542
OBIO
Orchestra BioMed Holdings, Inc. - Ordinary Shares
3.82 USD-4.26%-7.28%-7.28%+25.66%228.74 M USD
3551
CHRS
Coherus Oncology, Inc. - Common Stock
1.47 USD-4.55%-13.02%+2.80%-8.70%226.75 M USD
3552
NAUT
Nautilus Biotechnology, Inc. - Common Stock
1.78 USD-5.82%+4.09%-22.27%+131.17%226.20 M USD

Frequently asked questions about Karyopharm Therapeutics Inc. - Common Stock

What is the Karyopharm Therapeutics Inc. - Common Stock stock price today?

The current price of Karyopharm Therapeutics Inc. - Common Stock (KPTI) is 10.05. Over the past 24 hours, the stock has changed by -2.80%. Follow the KPTI chart for real-time price dynamics.

What is the stock ticker of Karyopharm Therapeutics Inc. - Common Stock?

Karyopharm Therapeutics Inc. - Common Stock trades under the ticker KPTI. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Karyopharm Therapeutics Inc. - Common Stock stock going up?

KPTI has changed by +4.91% over the last week, +4.15% over the last month, and +4.25% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was Karyopharm Therapeutics Inc. - Common Stock net income for the last quarter?

Karyopharm Therapeutics Inc. - Common Stock reported net income of -22.39 M for the last quarter. The previous quarter showed -102.2 M, which means net income changed by +78.09%.

How many employees does Karyopharm Therapeutics Inc. - Common Stock have?

As of the latest available data, Karyopharm Therapeutics Inc. - Common Stock has 228 employees. Workforce size can provide additional context about the company's scale and operations.

What is Karyopharm Therapeutics Inc. - Common Stock EBITDA?

Karyopharm Therapeutics Inc. - Common Stock EBITDA is -31.3 M, and its EBITDA margin is -111.15%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Karyopharm Therapeutics Inc. - Common Stock stock?

You can buy Karyopharm Therapeutics Inc. - Common Stock (KPTI) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Karyopharm Therapeutics Inc. - Common Stock stock?

Investing in Karyopharm Therapeutics Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the KPTI chart and related analysis on metatrader.com as part of your research.

News